Jay Hoofnagle, a Pioneer in Viral Hepatitis
BY SWAGATA ROYCHOWDHURY, NICHD
Once upon a time, no one knew much about hepatitis C—except to call it non-A, non-B hepatitis—unitl it was identified in 1989. Viral hepatitis pioneer Jay Hoofnagle (NIDDK) has been at the forefront of advancing hepatitis B and C therapeutics since coming to NIH in the 1970s. On Nov 12, 2014, he outlined the past and future therapies for hepatitis C at the annual Astute Clinician Lecture, part of the Wednesday Afternoon Lecture Series.
Read more